HopeStage
Back to all studies
CompletedNCT05446857

Glecaprevir/Pibrentasvir for the Treatment of PTSD

Researchers studied Glecaprevir / Pibrentasvir Pill to find out how it affected post-traumatic stress symptoms in people with PTSD.

Medication studyAges 19–70United States
The study in practice

Understand this study

What did researchers investigate?

Researchers studied Glecaprevir / Pibrentasvir Pill to find out how it affected post-traumatic stress symptoms in people with PTSD.

Who was this study for?

This study was for people with PTSD. Listed age limits: 19 years to 70 years. Other eligibility criteria applied.

Listed locations
White River Junction, United StatesSee all locations and recruitment
Activities
Medication described in the protocol
Compensation
Payment and expense reimbursement have not been verified.
Study clarity

Study information

Study start dateStarted: April 1, 2023
Recruitment status
Completed
Enrollment listed in the registry
10
Sponsor
White River Junction Veterans Affairs Medical Center
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2, Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 19 Years to 70 Years
Official registry ID
NCT05446857
Official title
Show the full official title

Glecaprevir/Pibrentasvir for the Treatment of PTSD

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

White River Junction

FAQ

Questions about this study

What did researchers investigate?

Researchers studied Glecaprevir / Pibrentasvir Pill to find out how it affected post-traumatic stress symptoms in people with PTSD.

Who is behind this study?

The study sponsor is White River Junction Veterans Affairs Medical Center, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Glecaprevir / Pibrentasvir Pill.

Who was this study for?

This study was for people with PTSD. Listed age limits: 19 years to 70 years. Other eligibility criteria applied.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me